| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -555,555 | 100% | $23.37 | -$12,983,320 |
| Net | -1 | -555,555 | -100% | -$12,983,320 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10%+ Owner | $91,823,464 | -$12,983,320 | -12% | 10 Dec 2025 |
| Robin LaChapelle | Chief Operating Officer | $8,896,571 | 02 Feb 2026 | ||
| James Healy | Director | $6,193,145 | 30 Jan 2024 | ||
| Carl L. Gordon | Director, 10%+ Owner | $5,524,874 | 30 Jan 2024 | ||
| ORBIMED ADVISORS LLC | Director, 10%+ Owner | $5,524,874 | 30 Jan 2024 | ||
| Jallal Bahija | Director | 25 Jan 2024 | |||
| Kristine Peterson | Director | 18 Jun 2025 | |||
| James Paul Kastenmayer | General Counsel | 02 Feb 2026 | |||
| Merdad Parsey | Director | 18 Jun 2025 | |||
| Winston Kung | Chief Financial Officer | 02 Feb 2026 | |||
| Stuart Lutzker | President of R&D, Director | 02 Feb 2026 | |||
| Chris Nolet | Director | 18 Jun 2025 | |||
| Zhengbin Yao | President and CEO, Director | 02 Feb 2026 | |||
| John Hohneker | Director | 18 Jun 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Robin LaChapelle | AVBP | Stock Option (right to buy) | Award | 130,000 | 130,000 | 02 Feb 2026 | Direct | |||
| Stuart Lutzker | AVBP | Stock Option (right to buy) | Award | 150,000 | 150,000 | 02 Feb 2026 | Direct | |||
| James Paul Kastenmayer | AVBP | Stock Option (right to buy) | Award | 130,000 | 130,000 | 02 Feb 2026 | Direct | |||
| Winston Kung | AVBP | Stock Option (right to buy) | Award | 140,000 | 140,000 | 02 Feb 2026 | Direct | |||
| Zhengbin Yao | AVBP | Stock Option (right to buy) | Award | 550,000 | 550,000 | 02 Feb 2026 | Direct | |||
| Hillhouse Investment Management, Ltd. | AVBP | Common Stock | Sale | -12.4% | $12,983,320 | $23.37 | -555,555 | 3,929,117 | 10 Dec 2025 | See footnotes |
| Robin LaChapelle | AVBP | Common Stock | Options Exercise | 8.95% | 11,153 | 135,736 | 11 Jul 2025 | Direct | ||
| Robin LaChapelle | AVBP | Stock Option (right to buy) | Options Exercise | -96.4% | -11,153 | 410 | 11 Jul 2025 | Direct | ||
| Merdad Parsey | AVBP | Non-Qualified Stock Option (right to buy) | Award | 15,502 | 15,502 | 18 Jun 2025 | Direct | |||
| Kristine Peterson | AVBP | Non-Qualified Stock Option (right to buy) | Award | 15,502 | 15,502 | 18 Jun 2025 | Direct | |||
| John Hohneker | AVBP | Non-Qualified Stock Option (right to buy) | Award | 15,502 | 15,502 | 18 Jun 2025 | Direct | |||
| Chris Nolet | AVBP | Non-Qualified Stock Option (right to buy) | Award | 15,502 | 15,502 | 18 Jun 2025 | Direct | |||
| Merdad Parsey | AVBP | Stock Option (right to buy) | Award | 28,346 | 28,346 | 28 Apr 2025 | Direct |